Clinical Trials
3 trialsNCT00543504 2020-06-30
Bevacizumab in Multiple Phase I Combinations
M.D. Anderson Cancer Center
Phase 1 Completed
NCT01287546 2017-02-15
A Study of LY2875358 in Participants With Advanced Cancer
Eli Lilly and Company
Phase 1 Completed
NCT00895128 2015-07-13
Study of Erlotinib in Combination With Dasatinib
M.D. Anderson Cancer Center
Phase 1 Completed